In this interview we discuss the goals of therapy in multiple myeloma, treatment combinations and transplantation, and how markers such as minimal residual disease are used.
Faith Davies, MD
Advertisement
Articles by Faith Davies, MD
Advertisement
Latest Updated Articles
Is Molecular Remission the Goal When Treating Myeloma?Published: December 8th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Safety Strategies for GPRC5D-Directed and T-Cell Engager Therapies
5
